Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 5154

Sort by

Sort Order Select

Journal Articles

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel

Blood Adv (2025) 9 (11): 2663–2676.

https://doi.org/10.1182/bloodadvances.2024013656

Published: 2025

Includes: Supplemental data

Journal Articles

A novel mouse model to study the effects of new therapies for Diamond-Blackfan anemia

Y. Lucy Liu, Nicholas Neoman, Kathleen M. Sakamoto

Blood Adv (2025) 9 (11): 2686–2690.

https://doi.org/10.1182/bloodadvances.2024015119

Published: 2025

Includes: Supplemental data

Journal Articles

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma

Blood Adv (2025) 9 (11): 2651–2662.

https://doi.org/10.1182/bloodadvances.2024015132

Published: 2025

Includes: Supplemental data

Journal Articles

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Dor Shpitzer, Yael C. Cohen, Tamir Shragai, Ori Grossberger, Dana Amsterdam, Anat Reiner-Benaim, Irit Avivi

Blood Adv (2025) 9 (11): 2677–2685.

https://doi.org/10.1182/bloodadvances.2025015968

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy

Jibran Durrani, Leonard N. Chen, Ruba N. Shalhoub, Valentina Baez, Joshua Glass, Nu Ri Cha, Xiaoyang Ma, Zhijie Wu, Shouguo Gao, Jennifer Lotter, Olga Rios, Colin O. Wu, Willy A. Flegel, Neal S. Young, Emma M. Groarke, Bhavisha A. Patel

Blood Adv (2025) 9 (11): 2639–2650.

https://doi.org/10.1182/bloodadvances.2024015301

Published: 2025

Includes: Supplemental data

Journal Articles

BCLAF1 restrains stress responses in hematopoietic stem cells to support expansion and repopulation

Stephanie J Crowley, Wei Yang, Lynn S White, Jun Wu, Yanan Li, Haley Schmidt, Kyunghee Choi, Jeffrey A Magee, Jeffrey J Bednarski

Blood Adv bloodadvances.2024014916.

https://doi.org/10.1182/bloodadvances.2024014916

Published: 2025

Includes: Supplemental data

Journal Articles

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

Ing-Soo S Tiong, Tamia Nguyen, Chong Chyn Chua, Charis E Teh, Christine Muttiah, Sarah Ftouni, John F Seymour, Daniel H D Gray, Andrew W Roberts, Sarah-Jane Dawson, Geoffrey J Lindeman, Piers Blombery

Blood Adv bloodadvances.2025016063.

https://doi.org/10.1182/bloodadvances.2025016063

Published: 2025

Includes: Supplemental data

Journal Articles

Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR

Blood Adv bloodadvances.2025016141.

https://doi.org/10.1182/bloodadvances.2025016141

Published: 2025

Includes: Supplemental data

Journal Articles

Weighing the evidence on GLP1s and venous thromboembolism

Damon E. Houghton, Karlyn A. Martin

Blood Adv (2025) 9 (10): 2458–2459.

https://doi.org/10.1182/bloodadvances.2025016052

Published: 2025

Journal Articles

John TD, Walters MC, Rangarajan HG, et al. Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. Blood Adv. 2024;8(23):6055-6063.

Blood Adv (2025) 9 (10): 2460.

https://doi.org/10.1182/bloodadvances.2025016356

Published: 2025

Journal Articles

Breaking the cycle: PRMTs and secondary HLH relief

Sakshi Malik, Shanmuganathan Chandrakasan

Blood Adv (2025) 9 (10): 2436–2437.

https://doi.org/10.1182/bloodadvances.2025015863

Published: 2025

Journal Articles

Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

Blood Adv (2025) 9 (10): 2570–2584.

https://doi.org/10.1182/bloodadvances.2024014177

Published: 2025

Journal Articles

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

Blood Adv (2025) 9 (10): 2587–2636.

https://doi.org/10.1182/bloodadvances.2024015328

Published: 2025

Includes: Supplemental data

Journal Articles

Kuaban A, Croker AK, Keefer J, et al. The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative. Blood Adv. 2025;9(4):687-695.

Blood Adv (2025) 9 (10): 2637.

https://doi.org/10.1182/bloodadvances.2025016358

Published: 2025

Journal Articles

Tocilizumab prophylaxis in double cord blood transplantation

William R. Drobyski

Blood Adv (2025) 9 (10): 2585–2586.

https://doi.org/10.1182/bloodadvances.2024015785

Published: 2025

Journal Articles

Inaccuracies of Venous Thromboembolism Risk Assessment and Prevention Practices Among Medically Ill Patients

Brandyn Lau, Aditya Bhave, Jennifer C Yui, Rakhi P. Naik, Kathryn E. Dane, John P Lindsley, Dauryne Shaffer, Peggy S Kraus, Erik H Hoyer, Elliott R Haut, Michael B. Streiff

Blood Adv bloodadvances.2024015306.

https://doi.org/10.1182/bloodadvances.2024015306

Published: 2025

Includes: Supplemental data

Journal Articles

A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse

Blood Adv bloodadvances.2025015797.

https://doi.org/10.1182/bloodadvances.2025015797

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders

Blood Adv bloodadvances.2024015406.

https://doi.org/10.1182/bloodadvances.2024015406

Published: 2025

Includes: Supplemental data

Journal Articles

The SAMD1 transcription factor coordinates hematopoietic lineage differentiation and H3K4 methylation status

Meg A Schaefer, Samantha L Gomez, Venkatasai Rahul Dogiparthi, Yichao J Zhou, Pooja Roy, Suhita J Ray, Linda Chee, Sandipan Brahma, sbrahma@unmc.edu, Robert Liefke, Kyle J Hewitt

Blood Adv bloodadvances.2024015627.

https://doi.org/10.1182/bloodadvances.2024015627

Published: 2025

Includes: Supplemental data

Journal Articles

PRIDE-FTG Advances Academic Careers of Underrepresented Early-Stage Investigators Performing Blood Disorders Research

Betty Sue Pace, Oluwatoyosi Onwuemene, Athena Starlard-Davenport, Rhea-Beth Markowitz, Vahé Heboyan, Petar Datsov, Treva Rice

Blood Adv bloodadvances.2024015727.

https://doi.org/10.1182/bloodadvances.2024015727

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel

A novel mouse model to study the effects of new therapies for Diamond-Blackfan anemia

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma

Clinical outcomes in older adults treated outside clinical studies: highlighting the octogenarian experience

Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy

BCLAF1 restrains stress responses in hematopoietic stem cells to support expansion and repopulation

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR

Weighing the evidence on GLP1s and venous thromboembolism

John TD, Walters MC, Rangarajan HG, et al. Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. Blood Adv. 2024;8(23):6055-6063.

Breaking the cycle: PRMTs and secondary HLH relief

Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients

Kuaban A, Croker AK, Keefer J, et al. The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative. Blood Adv. 2025;9(4):687-695.

Tocilizumab prophylaxis in double cord blood transplantation

Inaccuracies of Venous Thromboembolism Risk Assessment and Prevention Practices Among Medically Ill Patients

A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse

Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders

The SAMD1 transcription factor coordinates hematopoietic lineage differentiation and H3K4 methylation status

PRIDE-FTG Advances Academic Careers of Underrepresented Early-Stage Investigators Performing Blood Disorders Research

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only